MHRA Update including recall alert

MHRA Update including recall alert

January 7, 2019

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 pharmacy level medicines recall, to be actioned within 48 hours, for certain batches of  Irbesartan / Hydrochlorothiazide containing products. Actavis Group PTC EHF is recalling the batches identified below from pharmacies as a precautionary measure due to possible contamination with N-nitrosodiethylamine (NDEA). Community pharmacy teams should stop supplying the above products/batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process. To view the alert please visit the GOV.UK website.

Please note a new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 5 December 2018) was published in December 2018. To see the latest MHRA Drug Safety Update in full, visit the website.

More Latest News >

CD Alert

Emergency Information Alert System for Stolen Prescriptions, further details can be viewed here.

CPPE workshops

CPPE are running full day workshops: Confidence in Consultation Skills Clinical Medication Review Mental Health and Wellbeing Hypertension and prevention...

CPPE Asthma Workshops

Further details including dates and venues can be found here of the Asthma and Inhaler Workshops CPPE are currently running.

Patient and Public Volunteers

The Eastern Academic Health Science Network would like to ask your help with reaching out to communities and service user...

Winter advice videos

Hertfordshire and West Essex Sustainability and Transformation Partnership (STP) has produced two short videos to highlight some key winter advice...